LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

Lupinacci L, Railkar R, Taddeo FJ, Jansen
KU, Esser MT, Sings HL, Saah AJ, Barr E.
Prophylactic quadrivalent human papillomavirus
(types 6, 11, 16, and 18) L1 virus-like
particle vaccine in young women:
a randomised double-blind placebo-controlled
multicentre phase II efficacy trial.
Lancet Oncol 2005 May; 6(5):271-8.
258. Villa LL, Costa RL, Petta CA, Andrade RP,
Paavonen J, Iversen OE, Olsson SE, Hoye
J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom
A, Elfgren K, Krogh G,
Lehtinen M, Malm C, Tamms GM, Giacoletti
K, Lupinacci L, Railkar R, Taddeo FJ,
Bryan J, Esser MT, Sings HL, Saah AJ, Barr
E. High sustained efficacy of a prophylactic
quadrivalent human papillomavirus
types 6/11/16/18 L1 virus-like particle
vaccine through 5 years of follow-up. Br J
Cancer 2006 Dec 4; 95(11):1459-66.
259. Wald A, Langenberg AG, Link K, Izu AE,
Ashley R, Warren T, Tyring S, Douglas JM
Jr, Corey L. Effect of condoms on reducing
the transmission of herpes simplex
virus type 2 from men to women. JAMA
2001 Jun 27; 285(24):3100-6.
260. Walker DG, Walker GJ. Prevention of congenital
syphilis-time for action. Bull
World Health Organ. 2004 Jun; 82(6):401.
261. Wang S A, Weinstock H S, Knapp J S. Gonococcal
Isolate Surveillance Project
(GISP). CDC report. US Department of
Health and Human Services, 2005.
262. Ward D J, Rowe B, Pattison H, Taylor R S. Behavioural
interventions to reduce the risk
of sexually transmitted infections in genitourinary
medicine clinic patients:
a systematic review.West Midlands Health
Technology Assessment Collaboration
(WMHTAC) 2004 (DPHE Report No.
50): 97.
263. Wawer MJ, Sewankambo NK, Serwadda
D, Quinn TC, Paxton LA, Kiwanuka N,
Wabwire-Mangen F, Li C, Lutalo T, Nalugoda
F, Gaydos A, Moulton LH, Meehan
MO, Ahmed S, Gray RH. Control of sexually
transmitted diseases for AIDS prevention
in Uganda: a randomised community
trial. Rakai Project Study Group.
Lancet 1999 Feb 13; 353(9152):525-35.
264. Weinhardt L S, Carey M P, Johnson B T,
Bickham N L. Effects of HIV counseling
and testing on sexual risk behavior: a
meta-analytic review of published research,
1985-1997. Am J Public Health
1999; 89(9): 1397-1405.
265. Weller S, Davis, K. Efectividad del preservativo
en la reducción de la transmisión
del VIH en heterosexuales (Revisión
Cochrane traducida). En: La Biblioteca
Cochrane Plus, 2005 Número 3. Oxford:
Update Software Ltd. Disponible en:
http://www.update-software.com. (Traducida
de The Cochrane Library, 2004 Issue
3. Chichester, UK: John Wiley & Sons,
Ltd.). Acceso el 17/8/2005 en: http://
212.49.218.200/newgenClibPlus/ASP/pr
intDocument.asp
266. WHO.Guidelines on reproductive health
research and partners’ agreement.
Ethical Issues From the Programme’s document
Preparing a Project Proposal,
Guidelines and Forms (Third Edition). Acceso,
el 28/7/2005 en: http://www. who.
int/reproductive-health/hrp/guidelines_partners.en.html
267. WHO. Surveillance standards for antimicrobial
resistance. WHO Document
WHO/CDS/CSR/DSR/2001.5, 2001.
268. Wilkinson D, Ramjee G, Tholandi M, Rutherford
G. Nonoxinol-9 para prevenir el
contagio vaginal de infecciones de transmisión
sexual de hombres a mujeres (Revisión
Cochrane traducida). En: La Biblioteca
Cochrane Plus, 2005 Número 2.
Oxford: Update Software Ltd. Disponible
a: http://www.update-software.com.
(Traducida de The Cochrane Library,
2005 Issue 2. Chichester, UK: John Wiley
& Sons, Ltd.).
269. Wilkinson D, Ramjee G, Tholandi M, Rutherford
G. Nonoxynol-9 para prevenir el
174